4.6 Article

Bone Marrow-Derived Mast Cells Accumulate in the Central Nervous System During Inflammation but Are Dispensable for Experimental Autoimmune Encephalomyelitis Pathogenesis

Journal

JOURNAL OF IMMUNOLOGY
Volume 182, Issue 9, Pages 5507-5514

Publisher

AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.0801485

Keywords

-

Categories

Funding

  1. Canadian Institutes of Health Research (CIHR)
  2. AllerGen Network Centre of Excellence
  3. Multiple Sclerosis Society of Canada
  4. Michael Smith Foundation for Health Research
  5. Fonds de la Recherche en Sante

Ask authors/readers for more resources

Reports showing that W/W-v mice are protected from experimental autoimmune encephalomyelitis (EAE, a murine model of multiple sclerosis), have implicated mast cells as an essential component in disease susceptibility, but the role of mast cell trafficking has not been addressed. In this study, we have used both mast cell transplantation and genetic mutations (Cd34(-/-), W/W-v, W-sh/W-sh) to investigate the role of mast cell trafficking in EAE in detail. We show, for the first time, that bone marrow-derived mast cells are actively recruited to the CNS during EAE. Unexpectedly, however, we found that EAE develops unabated in two independent genetic backgrounds in the complete absence or mast cells or bone marrow-derived mast cell reconstitution. We conclude that although mast cells do accumulate in the brain and CNS during demyelinating disease via peripheral mast cell trafficking, they are completely dispensable for development of disease. The Journal of Immunology, 2009, 182: 5507-5514.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available